Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Age at Diagnosis
22%
Area under the Receiver Operating Characteristic (AUROC)
11%
Clinical Biomarkers
100%
Clinical Features
11%
Clinical Markers
11%
Clinical Predictors
11%
Clinically Significant
11%
Contrast Material
11%
Cox Regression
11%
EGFR mutation
22%
Enhanced Magnetic Resonance Imaging
11%
Extent of Resection
22%
Feature Parameter
11%
Genetic Biomarkers
100%
Genetic Modification
11%
Genomic Features
11%
Genomic Markers
11%
Glioblastoma
100%
Hemodynamic Parameters
11%
HIPAA
11%
Image Features
22%
Imaging Biomarkers
100%
Institutional Review Board
11%
Kaplan-Meier Estimator
11%
Karnofsky Performance Status
33%
Log-rank Test
55%
Median Survival
11%
Molecular Predictors
11%
Morphological Characteristics
11%
Multivariable
11%
Multivariable Model
22%
Mutant Epidermal Growth Factor Receptor
22%
Non-enhancing
100%
Outcome Prediction
100%
Overall Survival
33%
Patient Survival
11%
Perfusion Magnetic Resonance Imaging
11%
Poor Survival
33%
Pre-surgical
11%
Prognostic Capacity
11%
Prognostic Information
11%
Progression-free Survival
22%
Random Forest Model
11%
Relative Cerebral Blood Volume (rCBV)
88%
Resonant Dynamics
11%
Single Model
11%
Survival Model
11%
Survival Prediction
22%
T2-weighted Image
11%
Tumor
100%
Waiver
11%
White Matter Involvement
11%
Medicine and Dentistry
Biological Marker
100%
Clinical Imaging
100%
Clinical Predictor
20%
Contrast Medium
20%
Dynamic Susceptibility Contrast
20%
Epidermal Growth Factor Receptor
40%
Genetics
100%
Glioblastoma
100%
Hemodynamic
20%
Kaplan Meier Method
20%
Karnofsky Performance Status
60%
Log Rank Test
100%
Magnetic Resonance Imaging
20%
Morphology
40%
Neoplasm
100%
Overall Survival
60%
Perfusion Weighted Imaging
20%
Progression Free Survival
40%
Proportional Hazards Model
20%
Retrospective Study
20%
Student T Test
40%
Survival Prediction
20%
Immunology and Microbiology
Contrast Medium
33%
Dynamic Susceptibility Contrast
33%
Epidermal Growth Factor
66%
Hemodynamic
33%
Magnetic Resonance Imaging
33%
Morphology
66%
Overall Survival
100%
Perfusion Magnetic Resonance Imaging
33%
Progression Free Survival
66%
Random Forest
33%
Survival Prediction
33%
White Matter
33%
Wild Type
66%
Biochemistry, Genetics and Molecular Biology
Contrast Medium
25%
Dynamic Susceptibility Contrast
25%
Epidermal Growth Factor Receptor
50%
Genomics
100%
Hemodynamic
25%
Magnetic Resonance Imaging
25%
Morphology
50%
Overall Survival
75%
Perfusion Magnetic Resonance Imaging
25%
Progression Free Survival
50%
Random Forest
25%
Retrospective Study
25%
Survival Prediction
25%
Wild Type
50%
Neuroscience
Biological Marker
100%
Clinical Predictor
25%
Contrast Medium
25%
Dynamic Susceptibility Contrast
25%
Epidermal Growth Factor Receptor
50%
Genetics
100%
Magnetic Resonance Imaging
25%
Perfusion Magnetic Resonance Imaging
25%